Showing results (181-190 of 314) with videos related to

Sort By:
Pageof 32
European Heart Journal|January 27, 2009
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trialGerhard Wikstrom, Carina Blomström-Lundqvist, Bertil Andren, et al.
Eclinicalmedicine|April 24, 2023
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trialLouise China, Thais Tittanegro, Dominic Crocombe, et al.
The American Journal of Gastroenterology|August 15, 2022
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE TrialRishen Kutmutia, Thais Tittanegro, Louise China, et al.
BMJ (Clinical Research Ed.)|February 3, 2009
Antenatal peer support workers and initiation of breast feeding: cluster randomised controlled trialChristine MacArthur, Kate Jolly, Lucy Ingram, et al.
European Heart Journal|June 5, 2009
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) studyRudolf Berger, Aparna Shankar, Friedrich Fruhwald, et al.
International Journal of Clinical Practice|August 30, 2019
A trial of three non-invasive blood pressure monitors compared with invasive blood pressure assessment in atrial fibrillation and sinus rhythmWilliam Eysenck, Ahmed Ammar, Vijaya Kanthasamy, et al.
European Journal of Heart Failure|June 9, 2004
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failureJohn G F Cleland, Justin Ghosh, Nick Freemantle, et al.
European Journal of Heart Failure|December 26, 2006
Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplastyJohn G F Cleland, Alison P Coletta, Ahmed Tageldien Abdellah, et al.
BMJ Open|February 25, 2016
Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparisonNick Freemantle, David A Ginsberg, Rachael McCool, et al.
Midwifery|September 28, 2011
Effect of a peer support service on breast-feeding continuation in the UK: a randomised controlled trialKate Jolly, Lucy Ingram, Nick Freemantle, et al.
Pageof 32